Cabot Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Hold |
638
| – | – | 0.03% | 121 |
|
|
2025
Q1 | $317K | Hold |
638
| – | – | 0.04% | 110 |
|
|
2024
Q4 | $332K | Hold |
638
| – | – | 0.04% | 105 |
|
|
2024
Q3 | $395K | Sell |
638
-25
| -4% | -$15.5K | 0.05% | 107 |
|
|
2024
Q2 | $367K | Hold |
663
| – | – | 0.05% | 115 |
|
|
2024
Q1 | $385K | Hold |
663
| – | – | 0.05% | 122 |
|
|
2023
Q4 | $352K | Buy |
663
+9
| +1% | +$4.78K | 0.05% | 124 |
|
|
2023
Q3 | $331K | Buy |
654
+7
| +1% | +$3.54K | 0.05% | 123 |
|
|
2023
Q2 | $338K | Hold |
647
| – | – | 0.05% | 123 |
|
|
2023
Q1 | $373K | Hold |
647
| – | – | 0.06% | 117 |
|
|
2022
Q4 | $356K | Sell |
647
-413
| -39% | -$227K | 0.06% | 120 |
|
|
2022
Q3 | $538K | Buy |
1,060
+25
| +2% | +$12.7K | 0.09% | 111 |
|
|
2022
Q2 | $562K | Hold |
1,035
| – | – | 0.09% | 114 |
|
|
2022
Q1 | $611K | Hold |
1,035
| – | – | 0.08% | 112 |
|
|
2021
Q4 | $691K | Hold |
1,035
| – | – | 0.09% | 109 |
|
|
2021
Q3 | $591K | Hold |
1,035
| – | – | 0.08% | 114 |
|
|
2021
Q2 | $522K | Sell |
1,035
-4
| -0.4% | -$2.02K | 0.07% | 117 |
|
|
2021
Q1 | $474K | Buy |
1,039
+295
| +40% | +$135K | 0.07% | 114 |
|
|
2020
Q4 | $347K | Buy |
744
+122
| +20% | +$56.9K | 0.05% | 121 |
|
|
2020
Q3 | $275K | Buy |
622
+52
| +9% | +$23K | 0.05% | 121 |
|
|
2020
Q2 | $206K | Buy |
+570
| New | +$206K | 0.04% | 129 |
|